Characteristics | Brolucizumab N = 56 | Aflibercept N = 58 | P value |
---|---|---|---|
Age, years | Â | Â | Â |
Mean ± SD | 72.05 ± 11.03 | 70.17 ± 9.02 | 0.32 |
Median | 72.00 | 70.5 | Â |
Min, max | 51.00, 91.00 | 54.00, 91.00 | Â |
Sex, n (%) | Â | Â | 0.17 |
Male | 37 (66.1) | 30 (51.7) | Â |
Female | 19 (33.9) | 28 (48.3) | Â |
LogMAR BCVA | Â | Â | Â |
Mean ± SD | 0.84 ± 0.32 | 0.87 ± 0.27 | 0.63 |
Min, max | 0.28, 1.42 | 0.26, 1.30 | Â |
CMT (µm) |  |  |  |
Mean ± SD | 355 ± 89.7 | 365.5 ± 55.78 | 0.46 |
Min, max | 211.00, 598.00 | 265.00, 566.00 | Â |
Presence of IRF n (%) | 46 (82.1) | 44 (75.9) | 0.55 |
Presence of SRF n (%) | 46 (82.1) | 48 (82.8) |  > 0.99 |
Presence of SHRM n (%) | 24 (42.9) | 31 (53.4) | 0.35 |